Baduanjin Sequential Therapy and Cardiac Function of AMI With Reduced EF After PCI

Effect of Baduanjin Sequential Therapy on the Cardiac Function and Exercise Endurance in Patients With AMI and Reduced Ejection Fraction After Primary PCI

Acute myocardial infarction (AMI) is one of the leading causes of death around the world, with the potential for substantial morbidity and mortality. The increasing evidence indicates that exercise training has beneficial effects on LV remodelling in post-MI patients with greater benefits occurring when training earlier following MI, among which the earliest time for rehabilitation is one week after myocardial infarction. However, the effect of Baduanjin sequential therapy for patients after one week of AMI has yet to be assessed. Therefore, the aim of this study is to assess the impact of Baduanjin sequential therapy on cardiac and physical function in patients with AMI and reduced ejection fraction after primary PCI.

Inclusion Criteria:

• Acute myocardial infarction undergoing primary percutaneous coronary intervention;
• Aged 18 years or over and under 80 years;
• 35% < LVEF < 50% and LV < 65mm;
• With informed consents

Exclusion Criteria:

• Severe symptomatic congestive heart failure (KILLIP cardiac function class III-IV);
• Malignant arrhythmias (ventricular fibrillation, ventricular tachycardia, frequent multiple source ventricular premature);
• Uncontrolled hypertension (systolic blood pressure greater than 160mmhg, diastolic blood pressure greater than 100mmhg);
• Life-threatening diseases with limited life expectancy <6 months;
• Inability or difficulty to exercise;
• Participation in other clinical trials